“Europe has roughly double the population of the United States but lower pricing, so it’s a balancing act between how much volume can you get and how little price discount you give.” – Joshi Venugopal Joshi Venugopal, Head of Region
“Cell and gene therapy is in a winter period. We just need to hold our breath and adapt ourselves to the weather,” observed Miguel Forte, President of ISCT & CEO of Kiji Therapeutics. Miguel Forte chaired the Advanced Therapies UK
Your guide to choose the right Cell and Gene Therapy CDMOs for your company
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
